CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleLevered free cash flow is -$496.89M, lower than 95% of all stocks globally
- PositionCurrent ratio is 0.81×, lower than 95% of its Medical Instruments & Supplies peers (median 2.21×)
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
953.30MEUR1.11B · vs all stocks (USD)
Revenue (TTM)
2.32BEUR2.71B · vs all stocks (USD)
Profit Margin
-13.80%vs Medical Instruments & Supplies peers
Beta
0.4730xvs all stocks
52-Week Change
-40.00%vs all stocks
Market Capitalization
953.30MEUR1.11B · vs all stocks (USD)
Enterprise Value
3.12BEUR3.64B · vs all stocks (USD)
Forward P/E
8.18xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
0.4149xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
0.8906xvs Medical Instruments & Supplies peers
Enterprise to Revenue
1.34xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
8.71xvs Medical Instruments & Supplies peers
Profit Margin
-13.80%vs Medical Instruments & Supplies peers
Operating Margin
4.95%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
1.59%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
-24.41%vs Medical Instruments & Supplies peers
Revenue (TTM)
2.32BEUR2.71B · vs all stocks (USD)
Revenue per Share (TTM)
67.19EURUpdated Aug 21, 2026Quarterly Revenue Growth
22.00%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
548.29MEUR640.55M · vs all stocks (USD)
EBITDA (TTM)
331.88MEUR387.72M · vs all stocks (USD)
Net Income (TTM)
-320.32MEUR-374.21M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
28.28%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
209.53MEUR244.78M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-425.33MEUR-496.89M · vs all stocks (USD)
5-Year Average Dividend Yield
1.36%vs all stocks
Payout Ratio
5.88%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
25.86MEURFY2025 · Nov 30, 2025Revenue
2.32BEURFY2025 · Nov 30, 2025Cost of Goods Sold
1.90BEURFY2025 · Nov 30, 2025Gross Profit
425.25MEURFY2025 · Nov 30, 2025Operating Income
-70.79MEUR-82.70M · vs all stocks (USD)
Pre-tax Income
-330.13MEURFY2025 · Nov 30, 2025Income Tax Expense
-11.41MEURFY2025 · Nov 30, 2025Net Income
-318.72MEURFY2025 · Nov 30, 2025EBIT
-232.36MEURFY2025 · Nov 30, 2025EBITDA (Income Statement)
373.75MEURFY2025 · Nov 30, 2025Research & Development
80.98MEURFY2025 · Nov 30, 2025Selling, General & Administrative
381.14MEURFY2025 · Nov 30, 2025Other Operating Expenses
3.20MEURFY2025 · Nov 30, 2025Non-operating Interest Income
3.67MEURFY2025 · Nov 30, 2025Non-operating Interest Expense
97.77MEURFY2025 · Nov 30, 2025EPS (Basic)
-9.27EURFY2025 · Nov 30, 2025EPS (Diluted)
-9.27EURFY2025 · Nov 30, 2025Basic Shares Outstanding
34.54MSharesFY2025 · Nov 30, 2025Diluted Shares Outstanding
34.54MSharesFY2025 · Nov 30, 2025Net Income from Continuing Operations
-318.72MEURFY2025 · Nov 30, 2025Minority Interests (P&L)
-1.59MEURFY2025 · Nov 30, 2025Preferred Stock Dividends
0.00EURFY2025 · Nov 30, 2025Operating Cash Flow
-247.23MEURFY2025 · Nov 30, 2025Cash & Cash Equivalents (End of Period)
173.09MEURFY2025 · Nov 30, 2025Starting Profit (CF Statement)
-318.72MEURFY2025 · Nov 30, 2025Other Non-cash Items
105.34MEURFY2025 · Nov 30, 2025Change in Accounts Receivable (CF)
-38.47MEURFY2025 · Nov 30, 2025Change in Other Assets/Liabilities
4.62MEURFY2025 · Nov 30, 2025Net Acquisitions
-366.70MEURFY2025 · Nov 30, 2025Other Investing Activity
13.26MEURFY2025 · Nov 30, 2025Net Investing Cash Flow
-353.44MEURFY2025 · Nov 30, 2025Long-term Debt Issuance
1.64BEURFY2025 · Nov 30, 2025Long-term Debt Payments
-1.15BEURFY2025 · Nov 30, 2025Other Financing Charges
-1.15MEURFY2025 · Nov 30, 2025Net Financing Cash Flow
484.83MEURFY2025 · Nov 30, 2025Shares Outstanding
34.54MSharesUpdated Aug 21, 2026Float Shares
32.05MSharesUpdated Aug 21, 2026% Held by Insiders
11.42%vs all stocks
% Held by Institutions
75.02%vs all stocks
Total Cash (MRQ)
176.21MEUR205.86M · vs all stocks (USD)
Total Cash per Share (MRQ)
5.10EURUpdated Aug 21, 2026Total Debt (MRQ)
2.30BEUR2.69B · vs all stocks (USD)
Total Debt to Equity (MRQ)
2.08xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
0.8100xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
31.30EURUpdated Aug 21, 2026Total Assets
4.49BEUR5.25B · vs all stocks (USD)
Total Current Assets
1.10BEURFY2025 · Nov 30, 2025Total Liabilities
3.39BEURFY2025 · Nov 30, 2025Total Non-current Assets
3.39BEURFY2025 · Nov 30, 2025Total Non-current Liabilities
2.03BEURFY2025 · Nov 30, 2025Total Current Liabilities
1.36BEURFY2025 · Nov 30, 2025Cash & Cash Equivalents
176.21MEURFY2025 · Nov 30, 2025Other Short-term Investments
14.72MEURFY2025 · Nov 30, 2025Accounts Receivable
331.52MEURFY2025 · Nov 30, 2025Inventory
446.51MEURFY2025 · Nov 30, 2025Accounts Payable
426.97MEURFY2025 · Nov 30, 2025Short-term Debt
573.43MEURFY2025 · Nov 30, 2025Other Current Liabilities
103.11MEURFY2025 · Nov 30, 2025Long-term Debt
1.60BEURFY2025 · Nov 30, 2025Other Non-current Liabilities
724.00KEURFY2025 · Nov 30, 2025Common Stock (Book)
34.54MEURFY2025 · Nov 30, 2025Retained Earnings
907.05MEURFY2025 · Nov 30, 2025Total Shareholders' Equity
1.11BEUR1.29B · vs all stocks (USD)
52-Week Low
14.83EURUpdated Aug 21, 202652-Week High
46.72EURUpdated Aug 21, 202652-Week Change
-40.00%vs all stocks
Beta
0.4730xvs all stocks
50-Day MA
27.22EURUpdated Aug 21, 2026200-Day MA
24.55EURUpdated Aug 21, 2026Avg 10-Day Volume
109.56KSharesUpdated Aug 21, 2026Avg 30-Day Volume
170.31KSharesUpdated Aug 21, 2026Diluted EPS (TTM)
-9.27EURUpdated Aug 21, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Within or Near the Altman Distress Zone
Debt is a large share of its assets, and large against its cash flow.
Reads
Elevated Leverage on Three Denominators
Debt sits high against its equity, its assets, and its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Current ratio is 0.81×, lower than 95% of its Medical Instruments & Supplies peers (median 2.21×)Significant
Current ratio: 0.81Industry median: 2.21Industry P5: 0.86Peers compared: 65.00
Debt-to-equity is 2.08×, higher than 95% of its Medical Instruments & Supplies peers (median 0.23×)Significant
Debt-to-equity: 2.08Industry median: 0.23Industry P95: 1.26Peers compared: 65.00
Price-to-book is 0.89×, lower than 95% of its Medical Instruments & Supplies peers (median 2.65×)Notable
Price-to-book: 0.89Industry median: 2.65Industry P5: 0.93Peers compared: 65.00
Financial Health
Altman Z-Score 0.74: distress zoneCritical
Altman Z-Score: 0.74
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Levered free cash flow is -$496.89M, lower than 95% of all stocks globallySignificant
Levered free cash flow (USD): -496,891,782.68Global P5: -219,013,500
Revenue is $2.71B, above the global median of $520.53MNotable
Revenue (USD): 2,711,397,100.754Global Median: 520,528,949.311
Companies that share the same coordination system — how they create, deliver, or capture value.
Yibin Tianyuan Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Aradyan Technology Corp.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Guangzhou Newlife New Material Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shenzhen Click Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jiangsu Zhengdan Chemical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Batisoke Cimento Sanayi ve Ticaret A.S.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Aidite Qinhuangdao Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRule
Guangzhou Ruili Kormee Automotive Electronic Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Foshan Electrical and Lighting Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shijiazhuang Kelin Electric Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Shandong Longda Meishi Co., Ltd.
2 interpretationsWithin or Near the Altman Distress ZoneElevated Leverage on Three Denominators
China High-Speed Railway Co., Ltd.
2 interpretationsWithin or Near the Altman Distress ZoneElevated Leverage on Three Denominators
Yorhe Fluid Intelligent Control Co., Ltd.
2 interpretationsWithin or Near the Altman Distress ZoneElevated Leverage on Three Denominators